Xiuhua Fu

机构：Changchun University of Science and Technology, Xerox (France), Zhongshan Hospital, Inner Mongolia Medical University

发表论文 45 篇 · 总被引 242 次 · h-index 8

代表论文

• Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer (2024 · JAMA Oncology · 被引 63)
• Severe eosinophilic asthma in Chinese C‐BIOPRED asthma cohort (2022 · Clinical and Translational Medicine · 被引 29)
• BAI1‑associated protein 2‑like 2 is a potential biomarker in lung cancer (2018 · Oncology Reports · 被引 21)
• Efficacy and safety of MIL60 compared with bevacizumab in advanced or recurrent non-squamous non-small cell lung cancer: a phase 3 randomized, double-blind study (2021 · EClinicalMedicine · 被引 14)
• Ambient fine particulate matter and allergic symptoms in the middle-aged and elderly population: results from the PIFCOPD study (2023 · Respiratory Research · 被引 12)
• Plasma EGFR mutation abundance affects clinical response to first-line EGFR-TKIs in patients with advanced non-small cell lung cancer (2021 · Annals of Translational Medicine · 被引 12)